Red Wine's Link to Health Gains Support

New evidence suggests the mechanism of action for a red wine compound that some say is linked to a longer life span. Resveratrol acts directly on a protein that has been linked to cell metabolism and inflammatory diseases















Share on Tumblr

wine and glasses

Image: Getty Images

The discovery that a compound in red wine may provide a healthier and longer life had guaranteed popular appeal, but the suggestion has been attacked from all sides. One such skirmish — a debate about the hypothesized benefits of one particular compound — may now be resolved.

In Science this week, researchers show that the compound, called resveratrol, acts directly on a protein that has been linked to cell metabolism and inflammatory diseases.

“This will be a major step forward for the field,” says David Sinclair, a molecular biologist at Harvard Medical School in Boston, Massachusetts, and lead author of the study. ”The controversy has no doubt scared people off from studying these molecules.”

Unhealthy glow
A decade ago, Sinclair and his co-workers reported that resveratrol activated SIRT1, a member of a family of enzymes that remove acetyl groups from proteins and are thought to be involved in ageing and metabolism. The team's result was based on an assay that used a peptide bearing a tag that would fluoresce when the acetyl group was removed.

Shortly afterwards, Sinclair co-founded Sirtris, a company in Cambridge, Massachusetts, that used the assay to search for SIRT1-activating compounds that might serve as potential therapies for ageing-related diseases. Just four years later, GlaxoSmithKline (GSK), a large pharmaceutical company based in London, snatched up the company for US$720 million. It was a controversial acquisition, in part because GSK’s internal scientists couldn't reproduce the SIRT1 activation with untagged peptides.

They were not the only ones: other groups had reported that resveratrol boosted the activity of SIRT1 only when a bulky, hydrophobic tag was present on the peptide. “People thought it was an artifact,” says Brian Kennedy, chief executive of the Buck Institute for Research on Aging in Novato, California, and one of the researchers who initially reported concerns about the assay.

Direct evidence
But Sinclair and his colleagues now report that some of the naturally occurring targets that are amenable to SIRT1 activation by resveratrol and other such compounds have a common feature: bulky, hydrophobic amino acids at a key position. 

The team also identified a SIRT1 mutation that blocked the effects of resveratrol and other SIRT1-activating compounds on mitochondria

The study provides an important clarification, says Matt Kaeberlein, who studies ageing at the University of Washington in Seattle. But resveratrol interacts with numerous proteins, he adds, and it is still unclear to what extent the compound's biological effects are caused by its interaction with SIRT1.

And for now, those biological effects remain controversial, as laboratories quarrel over whether SIRT1 activation really does boost lifespan, notes Kaeberlein.

 “The field is overly polarized right now,” agrees Kennedy. “We need to find the correct middle ground.”

This article is reproduced with permission from the magazine Nature. The article was first published on March 7, 2013.



6 Comments

Add Comment
View
  1. 1. Acoyauh2 06:35 PM 3/8/13

    Middle ground my boots, science isn't a democracy.
    What you need to find is explanations and backing evidence. Opinions are a dime a dozen; produce the evidence and you silence controversy - either way.

    Reply | Report Abuse | Link to this
  2. 2. And Then What? 06:51 PM 3/8/13

    Since I just put down the last of a batch of ninety bottles I made I am personally thrilled and very soon I hope be thrilled a lot more on a regular basis.

    Reply | Report Abuse | Link to this
  3. 3. gpussetto 08:32 PM 3/8/13

    How does the conclusion : ' “The field is overly polarized right now,” agrees Kennedy. “We need to find the correct middle ground.” ' matches the tile of the article "Red Wine's Link to Health Gains Support"?

    Reply | Report Abuse | Link to this
  4. 4. popseal 10:40 PM 3/11/13

    I'll do my own research and so far I'm feeling pretty good about the lab work.

    Reply | Report Abuse | Link to this
  5. 5. david123 05:55 AM 3/12/13

    According to wikipedia, there's actually very little resveratrol in red wine. If the stuff really is worth something, it means taking it as a supplement. Sounds like that's a big If at this juncture.

    Reply | Report Abuse | Link to this
  6. 6. sunnystrobe 12:08 PM 3/14/13

    I heard it 'on the grapevine'... grapeskins are good for the longevity of grapes- shielding their precious seeds from ultraviolet sun damage - so what's good for them is good for us - it's as easy as that!
    Here in Australia, it's grape harvesting time in March now, wonderful dark-blue shiraz grapes waiting to be enjoyed, fermented or not. Long live resveratrol!

    Reply | Report Abuse | Link to this
Leave this field empty

Add a Comment

You must sign in or register as a ScientificAmerican.com member to submit a comment.
Click one of the buttons below to register using an existing Social Account.

More from Scientific American

See what we're tweeting about

Scientific American Editors

Tweets could not be retrieved at this time

Free Newsletters


Get the best from Scientific American in your inbox

Solve Innovation Challenges

Powered By: Innocentive

  SA Digital
  SA Digital

Email this Article

Red Wine's Link to Health Gains Support

X
Scientific American MIND iPad

Tap into your MIND

Get Both Print & Tablet Editions for one low price!

Subscribe Now >>

X

Please Log In

Forgot: Password

X

Account Linking

Welcome, . Do you have an existing ScientificAmerican.com account?

Yes, please link my existing account with for quick, secure access.



Forgot Password?

No, I would like to create a new account with my profile information.

Create Account
X

Report Abuse

Are you sure?

X

Institutional Access

It has been identified that the institution you are trying to access this article from has institutional site license access to Scientific American on nature.com. To access this article in its entirety through site license access, click below.

Site license access
X

Error

X

Share this Article

X